Synthesis, cytotoxic evaluation, and molecular docking studies of some new 1, 3, 4-oxadiazole-based compounds

(2020) Synthesis, cytotoxic evaluation, and molecular docking studies of some new 1, 3, 4-oxadiazole-based compounds. Research in Pharmaceutical Sciences. pp. 454-462. ISSN 1735-5362

[img]
Preview
Text
12734.pdf

Download (1MB) | Preview

Abstract

Background and purpose: Oxadiazole-derived compounds have been shown to have a wide range of pharmacological activities. 2, 5-Disubstituted 1, 3, 4-oxadiazole derivatives have occupied a specific place in the design of anti-proliferative agents. In the present work a series of 2, 5-disubstituted 1, 3, 4-oxadiazoles derivatives containing amide group has been synthesized via a two-step reaction. Experimental approach: A mixture of substituted carboxylic acid derivatives, semicarbazide, and phosphorus oxychloride in reflux condition yielded 2-amino-5-aryl-1, 3, 4-oxadiazole derivatives. Acylation of the amino group of the resultant oxadiazole with 6-chloronicotinoyl chloride in dry tetrahydrofuran/pyridine afforded the final products. The synthesized molecules were docked in the active sites of the epidermal growth factor receptor tyrosine kinase domain (PDB: 1M17) crystal structure to study the possible interactions with the active site. Cytotoxic activities of final products against HeLa and MCF-7 cells were also assessed by MTT assay. Findings/Results: Compounds IIb, IIc, and IIe had a considerable cytotoxic activity with IC50 values of 19.9, 35, and 25.1 mu M, respectively against HeLa cells. The highest docking score was -7.89 kcal/mol for compound IIe. Conclusion and implications: Compound IIe exhibited remarkable cytotoxic activity against the two tested cell lines particularly HeLa cells which was in accordance with the in silico Delta G bind result but further evaluations are necessary to prove these findings.

Item Type: Article
Keywords: Cytotoxicity Molecular docking Nicothionyl Oxadiazole ANTIMICROBIAL EVALUATION DERIVATIVES 1,3,4-OXADIAZOLES AGENTS
Subjects: QV Pharmacology
Divisions: Cardiovascular Research Institute > Applied Physiology Research Center
Cardiovascular Research Institute > Isfahan Cardiovascular Research Center
Faculty of Pharmacy and Pharmaceutical Sciences > گروه شیمی دارویی
Isfahan Pharmaceutical Sciences Research center
Page Range: pp. 454-462
Journal or Publication Title: Research in Pharmaceutical Sciences
Journal Index: ISI
Volume: 15
Number: 5
Identification Number: https://doi.org/10.4103/1735-5362.297848
ISSN: 1735-5362
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/12734

Actions (login required)

View Item View Item